Clin Cancer Res. 2009 Oct 1;15(19):5945-6. Epub 2009 Sep 29.

Inhibiting the hypoxia response for cancer therapy: the new kid on the block.

Source

Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas, USA.

Abstract

The hypoxia-inducible transcription factor (HIF)-1alpha inhibitor KC7F2 described in this issue of Clinical Cancer Research is the newest addition to an emerging class of antitumor agents targeting the hypoxia response. Here, we discuss the proposed mechanism of action of KC7F2 and its potential strengths and limitations in comparison with other promising HIF-1alpha inhibitors.

Comment on

Clin Cancer Res. 2009 Oct 1;15(19):6128-36.

PMID:: 19789327; [PubMed - indexed for MEDLINE]
PMCID:: PMC2760048

Free PMC Article

Images from this publication.See all images (1) Free text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Identification of a novel small molecule HIF-1alpha translation inhibitor. [Clin Cancer Res. 2009]
Identification of a novel small molecule HIF-1alpha translation inhibitor.
Narita T, Yin S, Gelin CF, Moreno CS, Yepes M, Nicolaou KC, Van Meir EG. Clin Cancer Res. 2009 Oct 1; 15(19):6128-36. Epub 2009 Sep 29.
Review Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets. [Curr Pharm Des. 2009]
Review Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets.
Dimova EY, Michiels C, Kietzmann T. Curr Pharm Des. 2009; 15(33):3867-77.
Review Role of hypoxia-inducible factor-1alpha as a cancer therapy target. [Endocr Relat Cancer. 2006]
Review Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
Patiar S, Harris AL. Endocr Relat Cancer. 2006 Dec; 13 Suppl 1:S61-75.
Review Hypoxia inducible factor-1alpha as a cancer drug target. [Mol Cancer Ther. 2004]
Review Hypoxia inducible factor-1alpha as a cancer drug target.
Powis G, Kirkpatrick L. Mol Cancer Ther. 2004 May; 3(5):647-54.
Review Development of novel therapeutic strategies that target HIF-1. [Expert Opin Ther Targets. 2006]
Review Development of novel therapeutic strategies that target HIF-1.
Semenza GL. Expert Opin Ther Targets. 2006 Apr; 10(2):267-80.

See reviews... See all...

Cited by 5 PubMed Central articles

Six degrees of separation: the oxygen effect in the development of radiosensitizers. [Transl Oncol. 2011]
Six degrees of separation: the oxygen effect in the development of radiosensitizers.
Oronsky BT, Knox SJ, Scicinski J. Transl Oncol. 2011 Aug; 4(4):189-98. Epub 2011 Aug 1.
Hypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells. [Mol Biol Cell. 2011]
Hypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells.
Chamboredon S, Ciais D, Desroches-Castan A, Savi P, Bono F, Feige JJ, Cherradi N. Mol Biol Cell. 2011 Sep; 22(18):3366-78. Epub 2011 Jul 20.
Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas. [BMC Cancer. 2011]
Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas.
Golinska M, Troy H, Chung YL, McSheehy PM, Mayr M, Yin X, Ly L, Williams KJ, Airley RE, Harris AL, et al. BMC Cancer. 2011 May 25; 11:198. Epub 2011 May 25.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Inhibiting the hypoxia response for cancer therapy: the new kid on the block.
Inhibiting the hypoxia response for cancer therapy: the new kid on the block.
Clin Cancer Res. 2009 Oct 1 ;15(19):5945-6. Epub 2009 Sep 29 .

PubMed
Conditioning as a critical determinant of sensitization induced by psychomotor s...
Conditioning as a critical determinant of sensitization induced by psychomotor stimulants.
NIDA Res Monogr. 1990 ;97:208-41.

PubMed
An evaluation of the sensitivity of acute flaccid paralysis surveillance for pol...
An evaluation of the sensitivity of acute flaccid paralysis surveillance for poliovirus infection in Australia.
BMC Infect Dis. 2009 Sep 30 ;9:162.

PubMed
Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin...
Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus.
Arch Intern Med. 1990 Dec ;150(12):2525-9.

PubMed
Bayesian computation and model selection without likelihoods.
Bayesian computation and model selection without likelihoods.
Genetics. 2010 Jan ;184(1):243-52. Epub 2009 Sep 28 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: